As millions of Americans take GLP‑1 medications like Ozempic, Wegovy and Mounjaro for weight loss or diabetes, doctors are noticing that some patients are developing previously unrecognized eating disorders due to the drugs’ powerful appetite-suppressing effects.
Health professionals across the country say they are seeing patients whose relationship with food and body image has taken a dangerous turn since starting the medications, which some experts are calling a new form of disordered eating.
